# K170661: Novosyn Quick Absorbable Suture

- Pathway: 510(k) (Traditional)
- Applicant: Aesculap, Inc.
- Decided: Jun 8, 2017 after 97 days
- Product code: GAM (Suture, Absorbable, Synthetic, Polyglycolic Acid)
- Device class: 2
- Regulation: 21 CFR 878.4493
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K980704 (1998). 5 ancestors in all.
No later device cites it as a predicate yet.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K122734: Aesculap Novosyn Absorbable Suture, Aesculap, Inc. (2012) Summary page 4.
- K962480: Coated Vicryl Rapide (Polyglactin 910) Braided, Synthetic Absorbable Suture, Undyed, ETHICON, Inc. (1996) Summary page 4.
- K944110: Vicryl Rapide Suture, ETHICON, Inc. (1995) Summary page 4.

## Indications for use
Novosyn Quick Absorbable Suture is indicated for use in general soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Novosyn Quick suture is not intended for use in ligation in ophthalmic, cardiovascular or neurological procedures.

Source page: https://510kreport.com/device/K170661
Methodology: https://510kreport.com/methodology
